Superdrug has announced a pay increase for newly qualified pharmacists, in a move that will see wages rise to £50,000 - ensuring that Superdrug Pharmacists
continue to receive the strongest renumeration package on the high street today.
Superdrug is also enhancing its patient experience and operational structure, with the introduction of a new role of Pharmacy Team Leader to selected pharmacy stores.
Pharmacy Team Leaders will be dispenser trained and provide a clear line of accountability for day-to-day dispensary activity including adhering to legal and
clinical frameworks whilst supporting, coaching, and developing a high-performing pharmacy team.
The role also allows Superdrug to offer a clear line of progression for talented Pharmacy Dispensers and Technicians who want to do more in their career and recognises
the valuable contribution Pharmacy Dispensers & Technicians play in community pharmacy.
In addition, the appointment of two new Heads of Pharmacy Operations sees the high street retailer driving and improving Superdrug's pharmacy performance to offer the
best possible care for patients. Craig Watt, Pharmacist and previously Area Manager, has been appointed to Head of Pharmacy Operations North and will be responsible
for the operation of Superdrug's central distribution hub serving its e-pharmacy and Online Dr team.
Ginger for Weight Loss
Ginger is a flavorsome and natural food that may help you supervise weight. Eating ginger fosters a feeling of fullness, an effect scientists call "satiety." Researchers at Columbia University in New York found that when bulky men drank a hot ginger drink, they had lowered feelings of appetite. Hunger can push us toward the consumption of foodstuffs. In many cases, we let our feelings of hunger evolve firmly, causing us to eat high-calorie edibles rich in sugar and fat, such as processed foods, which are well-documented to boost obesity.
According to Research, ginger:
Stimulates feelings of fullness
Improves blood sugar regulation
Decreases the amount of fat the gut absorbs
Reduces gut inflammation
Boosts the process of thermogenesis
Ease digestion by stimulating digestive enzymes
Help to Reduce Gas, Bloating, and Nausea
Improve the Health of Your Gut
How Does it Work?
Ginger is most well-known for its ability to ease your stomach, especially when floundering with nausea or bloating issues. In your belly, ginger is doing much better in facilitating weight management and improving your health. The gut microbiota is one of the most comprehensive research areas in obesity. Researchers know that tiny microbes in your gut greatly affect your body weight. Collectively, these little microbes are called gut microbiota. The types of foods consumed impact the gut microbiota. Ginger is one of the most widely used spices and has a healthy effect on gut microbes. Ginger emerges to lower gut inflammation and helps the body be better responsive to insulin, enabling improved blood sugar control and reduced weight gain.
A 2020 research study published in the European Journal of Nutrition noted that ginger changed the gut microbiota in rats in a manner that helped reduce obesity.
Stimulates Stomach Movement to Promote the Elimination of Waste Products
Ginger root is a natural digestive aid that can help promote the elimination of waste products in your b
The Pharmacists Defence Association (PDA) has welcomed the government's action of publishing 'AI Regulation White Paper' which will regulate the artificial
intelligence (AI) system used in pharmacy on Wednesday (29 March).
The Association had raised concerns about the risk of patient harm due to inappropriate use of so-called AI to include that seen in some of the pharmacy systems
undertaking clinical checks.
For some time, it has been receiving concerns from practicing pharmacists describing examples of the potentially detrimental impact of automation and online pharmacy
provision on patient safety and pharmacy practice.
As a result, it raised these concerns with regulators, Chief Pharmaceutical Officers, and parliamentarians in all four nations of the UK to urge action.
It said: "This is required not only to protect patients, but also the frontline pharmacists who could be blamed for potential harm caused by inappropriate use of so
called 'AI' systems implemented by their employer."
The PDA therefore, welcomes the announcement from the UK government that they intend to strengthen regulation of such technology, empowering existing regulators to
come up with tailored, context-specific approaches that suit the way AI is actually being used in their sectors; this will include pharmacy.
The Pharmacy Supervision Practice Group consisting of members from AIMp, APTUK, CCA, NPA, PDA, PFNI and RPS held its fourth workshop to continue discussions
on the future modelling of pharmacy practice.
The ideas around 'supervision' shared by the organisation earlier formed the basis of the discussion during the workshop and helped to expand understanding of where
there was consensus and disagreement.
Examples of ideas explored during the workshop include: the extent to which a pharmacist should supervise the medicines assembly process, the purpose and extent to
which a pharmacist might be absent from the pharmacy and how this might affect patient safety as well as the nature of whether fixed rules versus a broad framework
were preferable for future practice.
Chair of the group, Dr Michael Twigg, Associate Professor of Primary Care Pharmacy, University of East Anglia, said "Once again the sector bodies have come together
in a collaborative and positive manner to explore the concept of 'supervision' in the context of current and future community pharmacy practice. This session provided an opportunity to constructively challenge assumptions and viewpoints within the group with the aim of moving the discussion forward."
As part of the session, the DHSC, GPhC and PSNI gave an overview of the difference between legislation, regulation and guidance which was helpful to inform the
group's thinking. Each of the organisations have been asked to use the conversation to refine the ideas presented in advance of the next workshop.
The trade bodies and four largest pharmacy chains in England, have jointly written to the Secretary of State for Health, Steve Barclay, warning that the sector
needs urgent investment for sustainability.
The letter from AIMp, CCA, NPA, PSNC, Boots UK, Lloyds Pharmacy, Well, and Phoenix UK, warned that the 30 per cent real terms funding cuts that pharmacies have faced
over the past seven years have left many businesses in a cashflow crisis.
The letter said that the government is facing a choice over the future of the country's 11,000+ community pharmacies, with permanent closures likely and medicines
supply at risk if no urgent action is taken.
"If the funding situation is not addressed, the sector is likely to move rapidly towards many permanent closures of pharmacies."
The organisations say that once these closures start, they will be hard to stop, as the sector is now so fragile other pharmacies would struggle to pick up the slack.
A community pharmacy, Barton Pharmacy located in Woolacombe, Devon has been sold to a local pharmacist and its previous employee, Harminder Chaggar,
announced Christie & Co.
The business has been owned by Mr Osman Hamid for the last seven years and was brought to market to allow him to concentrate on his other business interests.
Barton Pharmacy is dispensing an average of 2,440 items per month. It lies completely unopposed in the highly desirable North Devon coastal village of Woolacombe,
in an Area of Outstanding Natural Beauty, and is an ever-popular holiday destination which boasts 'Beach of the Year 2021' as voted for by The Sunday Times.
Osman Hamid, previous owner of Barton Pharmacy, comments, "Owning this business for the last seven years has been an enjoyable experience, as we have had full
support from the NHS as it has an attached LPS contract and receives an overwhelmingly generous OTC income which is more than the average pharmacy. The business
has huge potential to grow and diversify into other avenues that are yet to be explored, and it is lovely to know that it has been passed onto a new owner operator
that I trust will do well with the business moving forwards."
AAH Pharmaceuticals (AAH) has announced the appointment of Brain Chambers as Chief Commercial Officer.
"I'm proud to lead the commercial functions in AAH in my new role and broader area of responsibility." Said Brian. "I'm committed to delivering on great value for
our customers and building and strengthening our supplier partnerships."
Brain is associated with AAH Pharmaceuticals for more than 14 years. He joined the organisation as Business Development Manager in October 2008. His previous role
in the organisation was on Sales and Marketing Director.
He posted on LinkedIn: "This is a big move for me personally, but that's a side hustle. What is the main play here is AAH becoming a standalone independent wholesale
business focussed on only the AAH customer and our core business and this is just one part of that.
The Medicines and Healthcare products Regulatory Agency (MHRA) made its new International Recognition procedure (IRP) fully operational from 1 January 2024,
inviting developers of new medicines to submit their applications for marketing authorisation.
Beginning this year, the EC Decision Reliance Procedure (ECDRP) has been replaced by IRP, and the Mutual Recognition/Decentralised Reliance Procedure (MRDCRP) has
come under its umbrella.
The move is expected to further improve access to life-saving medicines for UK patients following the UK's departure from the European Union.
In a groundbreaking move towards modernising healthcare, England's National Health Service (NHS) has successfully implemented digital prescriptions,
as reported by the World Health Organization (WHO) in its latest regional digital health report.
Since January 2024, patients across England have had access to their prescription information through the NHS App, marking a significant leap in healthcare
accessibility and efficiency.
With over 33 million registered users, representing 75 per cent of the adult population, the NHS App has become a vital tool in managing healthcare online.
The introduction of digital prescriptions allows users to order repeat prescriptions online without the need for a GP visit.
This innovation has witnessed a surge in digital requests, with over 3.1 million repeat prescriptions processed monthly.
"If we stand still, we will die. We have to keep moving, and we have to keep changing" said Patrick Gompels, co-owner of Gompels Limited, while emphasising
the need for innovation in community pharmacy services, during the recent Pharmacy Business Conference 2024.
Centered on the theme 'Pharmacy of Tomorrow,' the conference, held at the Hilton Wembley on April 28, focused on adopting and adapting innovative technology as
well as new ways of working and thinking to enhance patient services.
Patrick was joined by Mayank Patel of Pearl Chemist Group and Michael Lennox, CEO of Community Pharmacy Somerset (LPC), during the panel discussion on innovation
in community pharmacy services, moderated by Reena Barai, pharmacist and owner of S G Barai Pharmacy.
On the changes he made at Gompels, Patrick said: "The first thing we did was a complete overhaul of all of our systems. Pretty much everything was stripped down."
He shared that Gompels has embraced innovation by partnering with forward-thinking companies like Titan PMR, Drug Comparison, and Real World Analytics to enhance
their processes and data analysis capabilities.
The Pharmacists' Defence Association (PDA) is bolstering its leadership team with the appointment of Jay Badenhorst as the Director of Pharmacy, a newly
created position aimed at fortifying its commitment to advancing pharmacy practice.
This move comes amidst a period of significant change and challenge for frontline pharmacists, prompting the independent trade union to enhance its influence
in the evolving healthcare landscape.
Mr. Badenhorst, who previously served Whitworth Chemists as the Managing Director and also has leveraged his extensive knowledge of the pharmacy practice and
organisational leadership as the Vice Chair of the National Pharmacy Association, reasons his "commitment to being at the forefront of positive change within
the pharmacy profession."
Mr. Badenhorst expressed his enthusiasm stating: "I am delighted to be joining an organisation that has so much vision, ambition and drive at a time when
pharmacists have so many opportunities to develop their roles for the benefit of patients."
According to Mark Koziol, Chair of PDA, the new position is a reflection of the union's commitment to pharmacy and described the new Director of Pharmacy
as "a senior level, proven and award-winning pharmacy leader."
With the upcoming general election on the horizon, Proprietary Association of Greater Britain (PAGB) is leading the charge to integrate self-care into the
core of all political party manifestos.
The aim is to ease strains on the NHS and forge a sustainable healthcare system for the future.
In a significant move, PAGB unveiled a comprehensive general election toolkit on Wednesday, laying out a compelling argument for the prioritisation of self-care
among stakeholders.
The toolkit underscores the importance of public interest, potential NHS cost savings, and the economic advantages of the over-the-counter (OTC) sector.
Aimed at unlocking the full potential of self-care and nurturing an enabling environment for its implementation, PAGB's toolkit advocates for greater integration
of pharmacy services into primary care.
A new bill was introduced to Parliament on Wednesday (20 March) to prohibit the sale of tobacco to children under the age of 15, delivering on the
Prime Minister's commitment to create a smokefree generation.
The Tobacco and Vapes Bill aims to protect future generations from the harmful impacts of smoking, thereby saving thousands of lives and billions of pounds
for the NHS.
The bill will also introduce new powers to restrict vape flavours and packaging deliberately targeted towards children, as well as allow the government to
change how they are displayed in shops, moving them out of sight of children and away from products that appeal to them, like sweets.
Additionally, enforcement officers' powers will be strengthened with 'on the spot fines' of £100 to ensure compliance with the new laws. This complements
the existing maximum fine of £2,500 that local authorities can already impose. It will also become illegal to provide free samples of vapes to children under
the age of 18.
In a move to make healthcare more accessible, the Department of Health and Social Care (DHSC) has announced plans to empower pharmacy technicians, dental
therapists, and hygienists with enhanced authority following two public consultations run by the government in 2023.
Revealed by Primary Care Minister Andrea Leadsom on Thursday 28th March, this strategic decision promises to usher in "a faster, simpler, and fairer access to
primary care" by granting pharmacy professionals "the ability to both supply and administer medications".
Based on the public consultations that garnered widespread support, with 97% backing the empowerment of dental hygienists and therapists and 84% favouring similar
rights for pharmacy technicians, the new reform is aimed to cut through bureaucratic red tape and bolster efficiency in patient care.
Dental hygienists and therapists, under the proposed change, will be empowered to administer select medications, including pain relief and fluoride, without the
need for dentist approval.
In a bid to bolster professional leadership within the pharmacy sector, the four government Chief Pharmaceutical Officers (CPhOs) have embarked on a
significant initiative, forming the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB).
In a recent communication, all pharmacists and pharmacy technicians received confirmation of the board members selected by the CPhOs, alongside a note from the
board's appointed chair, who was chosen collectively by the four CPhOs and reports directly to the CPhO for England.
Over three years, the 21-member Board will implement recommendations from the UK Commission on Pharmacy Professional Leadership's report aimed to enhance
professional fulfillment among pharmacists while simultaneously augmenting patient safety standards.
This announcement also follows with the appointment of Sir Hugh Taylor as its Independent Chair and the appointment of Independent Expert Members who expressed
his delight over the role's "potential to lead and support collaboration across the professions in the UK".
However, the move has been met with cautious optimism from the Pharmacists' Defence Association (PDA), urging the new board to uphold transparency and openness
to garner trust among pharmacists.
The Department of Health and Social Care (DHSC) made a recent announcement that the Incubator for Artificial Intelligence (i.AI) and NHS England (NHSE) have
joined forces in a groundbreaking move by signing a Collaboration Charter on AI.
This pivotal partnership aims to equip the NHS workforce with the tools and resources to leverage AI technology for enhancing patient care, improving staff
experience, and driving operational efficiency.
The Charter, endorsed by Minister Burghart, Parliamentary Secretary for the Cabinet Office, and Lord Markham, Parliamentary Under Secretary of State at the DHSC,
signifies an important step towards integrating AI into the fabric of the NHS.
Under this collaboration, the i.AI team, comprising elite technical experts within the government, will identify opportunities where AI technology can be deployed
responsibly to support the NHS.
This initiative is expected to streamline processes, optimize resource allocation, and ultimately enhance patient outcomes.
Aspire Pharma Limited has reaffirmed its commitment to combating prostate cancer by adding leuprorelin acetate as a branded generic to its oncology
portfolio. This move solidifies Aspire's position as a leading specialty generics enterprise.
Leuprorelin acetate is a hormone therapy recommended for patients with high-risk localized, locally advanced, and metastatic prostate cancer. It serves as an
alternative to surgical castration for locally advanced cases. A pre-filled syringe containing 11.25mg of leuprorelin acetate (equivalent to 10.72 mg leuprorelin)
is injected subcutaneously into the abdomen, providing a vital treatment option for patients.
Join the battle against pain! Worldwide, 93% experience it annually, with 1 in 3 enduring daily agony. But our approach needs refinement. Introducing
our Pain Management Webinar! In just 60 minutes, equip yourself with strategies to combat pain effectively. Here's what's covered:
Pharmacists' Evolving Role: Moving beyond medication.
Perfecting Pain Assessment: Quantifying patient discomfort.
#ListenToPain: Enhancing patient communication.
Tailored for British pharmacists addressing acute and chronic pain. Seize this opportunity to make a tangible difference. Reserve your spot now for invaluable
insights!
In a groundbreaking move, the Department of Education has initiated the first phase of its ambitious childcare expansion plan, offering a lifeline to
thousands of working parents of two-year-olds nationwide.
Effective from April 1, working parents now have access to 15 hours a week of government-funded childcare, marking the onset of the largest-ever childcare
provision expansion in the country's history.
This milestone initiative aims to alleviate the financial strain on families and promote workforce participation, with over 150,000 children projected to benefit
from government-funded places.
By September 2025, the expansion will culminate in working parents gaining access to 30 hours of free childcare, offering substantial annual savings and enabling
parents to navigate the delicate balance between work and family commitments.
Acknowledging the pivotal role of childcare in supporting families and driving economic growth, Prime Minister Rishi Sunak emphasized the government's commitment
to delivering on its promise of expanded childcare provision.
The Department of Health and Social Care (DHSC) is pushing ahead with its plans to implement a new drug tariff from April 2024. However, this move has
sparked strong opposition from Community Pharmacy England (CPE), raising concerns about its potential impact on pharmacies and patients.
Earlier, it was announced that the April drug tariff will include the new 'Retrospective top-up payment for Concessionary prices, which will be applied
automatically for the products listed in Part VIIIE each quarter by the NHS Business Services Authority (NHSBSA), according to the volume the contractor was
paid for.
However, CPE argued that the government has imposed these "untested" changes without their agreement, and strongly opposed them stating that "no recovery or
downward pressure on margin is acceptable given the financial fragility of community pharmacies."
Janet Morrison, chief executive of CPE, has voiced strong opposition to these changes, arguing that "any system expecting pharmacies to dispense at a loss"
jeopardises the sector's financial stability and compromises patient care.